M ultipotent progenitors from the bone marrow colonize the thymus and differentiate into various T cell lineages in response to environmental cues. Such signals induce specific cell-intrinsic transcriptional programs. The molecular mechanisms driving these lineage-fate 'decisions' have been the focus of intense research that has resulted in the identification of several pivotal transcription factors. For example, regulation of γδ-versus-αβ T cell differentiation is mediated by Sox13 (ref. 1) , whereas Th-Pok acts as a 'master regulator' of the CD4-versus-CD8 commitment step 2 . Similarly, Foxp3 is indispensable for the differentiation of regulatory T cells 3 . In this issue of Nature Immunology, Sant'Angelo and colleagues report an essential function for the promyelocytic leukemia zincfinger transcription factor PLZF in the development of invariant natural killer T (iNKT) cells 4 . Although a few iNKT cells can be found in mice deficient in PLZF, they do not seem to acquire the phenotype and 'innate-like' characteristics usually associated with this population, which suggests an essential function for PLZF in iNKT cell biology.
NKT cells represent a distinct subset of T lymphocytes that has evolved to recognize glycolipid antigens presented by the nonclassical major histocompatibility complex class I-like molecule CD1d. After recognizing glycolipids, NKT cells respond within hours by secreting large quantities of cytokines and chemokines, reminiscent of innate rather than adaptive functions. These cells have been linked to the regulation of immune responses
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Natural killer T cells acquire their unique phenotype and characteristics during development in the thymus. Evidence suggests that the transcription factor PLZF has a unique function in the development of these cells and their acquisition of 'innate-like' characteristics.
associated with a broad range of disorders, including autoimmunity, infectious disease and cancer.
Type I NKT cells, also called 'iNKT cells', are the most prevalent NKT cells in mice. They are characterized by the expression of a single invariant T cell receptor (TCR) α-chain (V α 14-J α 18 in mice; V α 24-J α 18 in humans) in combination with certain TCRβ chains (using V β 8.2, V β 7 or V β 2 in mice, or V β 11 in humans). Although the iNKT cell population is composed of many clones that express different combinations of these TCRs, their uniform reactivity to CD1d tetramers loaded with the glycosphingolipid antigen α-galactosylceramide allows the iNKT cell population to be tracked as a whole. This technical advantage has permitted the study of iNKT cell development in many genetically modified strains of mice and has led to the identification of several transcription factors and signaling pathways important for this process.
The iNKT cells develop in the thymus, where they segregate from conventional T cell development at the CD4 + CD8 + doublepositive (DP) thymocyte stage, coincident with the acquisition of TCRαβ expression. Like the development of conventional T cells, iNKT cell development requires recognition of their restriction element, in this case CD1d, by the iNKT TCR. Both DP thymocytes and epithelial cells in the thymus express CD1d. However, iNKT cells are positively selected at the DP stage by CD1d-expressing DP cells themselves, in contrast to the selection of 'conventional' T cells, which is usually driven by interaction with epithelial cells. It is thought that selection by DP cells imparts the unique developmental program of iNKT cells to the selected thymocytes because of homotypic interactions across the DP cell-DP cell synapse that generate 'second signals' mediated by the cooperative engagement of the homophilic receptors of at least two members of the signaling lymphocyticactivation molecule (SLAM) family (SLAMF1 (also called SLAM and CD150) and SLAMF6 (also called Ly108)) 5 . Such engagements lead to 'downstream' recruitment of the adaptor SLAM-associated protein (SAP) and the Src kinase Fyn, both of which are essential for the expansion and differentiation of the iNKT cell lineage. Notably, CD4 + T cells positively selected by thymic cells expressing major histocompatibility complex class II also require these signals and share several features with iNKT cells 6 .
Once iNKT cells have been positively selected, they expand their populations in the thymus and undergo orchestrated maturation that ultimately leads to their acquisition of the activated NK cell-like phenotype (Fig. 1) . This process relies on the proper expression of cytokine receptors, signal-transduction molecules, transcription factors and costimulatory molecules 7 . However, none of the genes encoding molecules previously shown to participate in iNKT cell development are expressed exclusively in iNKT cells. By screening various thymocyte populations for the expression of several members of BTB-ZF family of transcription factors, Kovalovsky et al. find that PLZF is uniquely expressed in iNKT cells 4 . With a combination of intracellular PLZF staining and quantitative PCR to measure PLZF mRNA expression, they show high expression of PLZF in iNKT cells and a lack of expression in other immune cells, such as 'conventional' T cells, NK cells, B cells, neutrophils, eosinophils and macrophages. PLZF expression is highest in CD24 hi CD44 lo thymic iNKT cells, a population thought to represent immature iNKT cells that have just undergone positive selection 8 . In agreement with another study of gene expression in developing iNKT cells (Affymetrix probe set 1419874_x_at) 9 , they find that PLZF expression decreases as the cells mature, but PLZF expression remains higher in mature iNKT cells than in other lymphoid populations.
What are the signals that induce PLZF expression in the early development of iNKT cells? Two signaling events are known to be critical for the making of an iNKT cell. The first involves recognition of CD1d + self glycolipids by the semi-invariant TCRs; the second requires the engagement of SLAM family receptors. Because PLZF is expressed in wild-type amounts in the very few iNKT cells that can be found in mice deficient in Fyn or SAP, two signaling molecules that convey the SLAM-mediated signals, Kovalovsky et al. conclude that SLAM-mediated signaling is probably not essential for PLZF expression 4 . Although not definitive, these results suggest that perhaps a third, unknown signal is necessary for the induction of PLZF expression. The surface molecules and cell types that might be involved in the PLZF-inducing pathway will probably be the focus of intense research in the near future.
PLZF has been linked to the regulation of hip development, spermatogenesis, hematopoietic proliferation and differentiation, leukemogenesis and tumorigenesis. It is generally thought of as a transcriptional repressor because of its ability to recruit mammalian members of the Polycomb family, which in turn recruit histone deacetylases. In the absence of PLZF, very few iNKT cells develop, and the cells that are detected fail to fully upregulate several cell surface markers usually associated with the maturation of iNKT cells. These 'immature' iNKT cells tend to accumulate in the lymph nodes and are deficient in several effector functions, such as the ability to rapidly secrete interleukin 4 (IL-4) and interferon-γ after TCR triggering. These results suggest that PLZF controls, either directly or indirectly, several genes that are important for iNKT cell biology (including cytokine secretion, cytotoxicity and migration). In future studies, it will be important to determine how PLZF acts in iNKT cells to control these various aspects of iNKT cells' biology. Published reports have shown that PLZF directly inhibits the expression of at least three different microRNAs in melanoma and megakaryocytes 10, 11 . In turn, these single-stranded 20-to 25-nucleotide noncoding RNAs regulate gene expression by targeting protein-coding mRNA for translational repression and/or degradation. The presence of untranslated IL-4 mRNA in resting iNKT cells represents one of the hallmarks of the population. The absence of this 'preformed' IL-4 mRNA in resting PLZF-deficient iNKT cells could be consistent with such a mechanism of regulation, either through the direct binding of microRNAs to the 3′ untranslated region of the IL-4 mRNA or, alternatively, through the indirect regulation of genes involved in regulating message stability.
The localization and migratory activity of the various cells that populate lymphoid tissues seem to be linked to their unique functions. Determining these parameters for iNKT cells should contribute greatly to the understanding of how these cells participate in the immune response. Just as the generation of CD1d tetramers loaded with α-galactosylceramide revolutionized and refined how researchers could study iNKT cells ex vivo 12, 13 , the identification of Zbtb16, which encodes PLZF, as an iNKT cell-specific gene might be a critical stepping stone in advancing the effort to study iNKT cells in vivo. The identification of PLZF as a 'signature' gene product of iNKT cells opens the possibility of developing reagents to use PLZF as a molecular tracer of the population in vivo. It is unclear at present whether the new monoclonal antibody to PLZF developed in the Sant'Angelo laboratory 4 will be useful for immunohistochemistry. However, PLZF could be used, as has been done with Foxp3 and regulatory T cells, in 'knock-in' and/or bacterial artificial chromosome transgenic approaches to take advantage of the genomic regulatory regions of Zbtb16. The expression of genes of interest could be driven or abrogated in an iNKT cell-specific way to track and/or modulate iNKT cell activities directly in vivo. One potential complication of the immediate usefulness of the identification of Zbtb16 as a gene specifically expressed in iNKT cells has been demonstrated by microarray data derived from blood monocytes 1010 volume 9 number 9 september 2008 nature immunology Figure 1 Model of iNKT cell development. NKT cells arise in the thymus from uncommitted CD4 -CD8 -double-negative (DN) precursors. The cells progress to the DP stage, at which they randomly rearrange their TCR. Thymocytes expressing a TCR that interacts with CD1d bound to self glycolipid expressed by other DP thymocytes enter the iNKT lineage. Homotypic interactions between SLAM and Ly108, also expressed at the surface of DP thymocytes, are required for progression into the iNKT cell lineage. After selection, iNKT cell precursors undergo a series of differentiation steps characterized by the sequential expression of several cell surface markers (CD24, CD44 and NK1.1). The earliest iNKT cell precursor found in the thymus has the highest expression of PLZF; this then decreases as the cells progress further along the differentiation pathway. At least four distinct immature iNKT cell populations have been identified in the thymus. Most iNKT cells that emigrate from the thymus do so as immature (CD44 hi NK1.1 -) cells and continue their final maturation in the periphery. This final maturation step is controlled by the transcription factor T-bet, whose expression increases as a function of iNKT cell development. Some mature iNKT cells also migrate to the periphery, but many remain as long-term residents of the thymus. In absence of PLZF (right), the cells fail to fully mature and 'preferentially' accumulate in the lymph nodes instead of the spleen and the liver, where wildtype iNKT cells usually reside. N e w S A N D v I e w S purified on the basis of forward scatter, side scatter and CD11b expression 14 , which have shown high expression of PLZF in this monocyte population. This cell population was not examined in the study by Kovalovsky et al. 4 , and the results must be confirmed before PLZF can be formally designated an iNKT cell-specific transcription factor. Nevertheless, the findings reported here by Kovalovsky et al. represent an important milestone in the understanding of iNKT cell development and will probably open new areas of investigation of this unique lymphocyte population.
